Simplex Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $750K | Sell |
25,000
-100
| -0.4% | -$2.84K | ﹤0.01% | 3113 |
|
|
2026
Q1 | $753K | Buy |
25,100
+24,500
| +4,083% | +$811K | ﹤0.01% | 2795 |
|
|
2025
Q4 | $19.6K | Sell |
600
-900
| -60% | -$29.1K | ﹤0.01% | 6490 |
|
|
2025
Q3 | $51K | Buy |
1,500
+100
| +7% | +$3.2K | ﹤0.01% | 6440 |
|
|
2025
Q2 | $39K | Sell |
1,400
-800
| -36% | -$21.4K | ﹤0.01% | 6166 |
|
|
2025
Q1 | $55K | Buy |
2,200
+1,400
| +175% | +$35.4K | ﹤0.01% | 5660 |
|
|
2024
Q4 | $22K | Sell |
800
-600
| -43% | -$16.7K | ﹤0.01% | 6605 |
|
|
2024
Q3 | $40K | Sell |
1,400
-30,600
| -96% | -$833K | ﹤0.01% | 6084 |
|
|
2024
Q2 | $792K | Buy |
32,000
+26,400
| +471% | +$749K | ﹤0.01% | 3165 |
|
|
2024
Q1 | $180K | Sell |
5,600
-8,800
| -61% | -$327K | ﹤0.01% | 4976 |
|
|
2023
Q4 | $585K | Sell |
14,400
-2,000
| -12% | -$73.6K | ﹤0.01% | 3525 |
|
|
2023
Q3 | $566K | Sell |
16,400
-37,400
| -70% | -$1.46M | ﹤0.01% | 3262 |
|
|
2023
Q2 | $2.19M | Sell |
53,800
-19,200
| -26% | -$783K | ﹤0.01% | 1911 |
|
|
2023
Q1 | $2.82M | Buy |
73,000
+42,300
| +138% | +$1.74M | ﹤0.01% | 1672 |
|
|
2022
Q4 | $1.36M | Buy |
30,700
+24,300
| +380% | +$1.02M | ﹤0.01% | 2181 |
|
|
2022
Q3 | $272K | Buy |
6,400
+2,000
| +45% | +$102K | ﹤0.01% | 4210 |
|
|
2022
Q2 | $245K | Sell |
4,400
-23,200
| -84% | -$1.38M | ﹤0.01% | 4364 |
|
|
2022
Q1 | $1.71M | Buy |
27,600
+26,000
| +1,625% | +$1.59M | ﹤0.01% | 2269 |
|
|
2021
Q4 | $88K | Sell |
1,600
-2,900
| -64% | -$151K | ﹤0.01% | 6456 |
|
|
2021
Q3 | $315K | Hold |
4,500
| – | – | ﹤0.01% | 4829 |
|
|
2021
Q2 | $310K | Buy |
4,500
+4,340
| +2,713% | +$331K | ﹤0.01% | 4927 |
|
|
2021
Q1 | $1.23M | Buy |
+160
| New | +$14.7K | ﹤0.01% | 2162 |
|
|
2020
Q4 | – | Sell |
-54
| Closed | -$766K | – | 8584 |
|
|
2020
Q3 | $766K | Buy |
54
+2
| +4% | +$333 | ﹤0.01% | 2539 |
|
|
2020
Q2 | $1.02M | Sell |
52
-1
| -2% | -$207 | ﹤0.01% | 2129 |
|
|
2020
Q1 | $1.04M | Sell |
53
-149
| -74% | -$32.1K | ﹤0.01% | 1847 |
|
|
2019
Q4 | $4.18M | Buy |
202
+59
| +41% | +$10.9K | 0.01% | 919 |
|
|
2019
Q3 | $2.18M | Sell |
143
-212
| -60% | -$34.7K | 0.01% | 1273 |
|
|
2019
Q2 | $4.58M | Buy |
355
+227
| +177% | +$26.9K | 0.01% | 726 |
|
|
2019
Q1 | $1.51M | Buy |
+128
| New | +$12.9K | ﹤0.01% | 1626 |
|
|
2018
Q1 | – | Sell |
-2
| Closed | -$1K | – | 6391 |
|
|
2017
Q4 | $1K | Buy |
+2
| New | +$189 | ﹤0.01% | 5507 |
|
|
2017
Q3 | – | Sell |
-2
| Closed | -$8K | – | 6147 |
|
|
2017
Q2 | $8K | Buy |
+2
| New | +$168 | ﹤0.01% | 4162 |
|
Other funds holding LKFT
Simplex Trading's LKFT Position: Q2 2026 in Review
Simplex Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 15% in Q2 2026, buying an estimated $31.1K and bringing the position to 8,323 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.
Simplex Trading first reported a position in LKFT in Q2 2017 and has held it in 19 quarters since. The position peaked at $3.72M in Q2 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Simplex Trading held 8,323 shares of Lakefront Biotherapeutics American Depositary Shares worth $250K as of Q2 2026.
- Simplex Trading bought 1,096 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $31.1K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4443 holding.
- Simplex Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 19 quarters since.
- Simplex Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.72M in Q2 2020.
- 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.